Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 32% ± 14% | |
astrocyte | 14 studies | 35% ± 15% | |
oligodendrocyte | 13 studies | 36% ± 15% | |
glutamatergic neuron | 11 studies | 35% ± 26% | |
microglial cell | 11 studies | 29% ± 12% | |
oligodendrocyte precursor cell | 11 studies | 40% ± 18% | |
GABAergic neuron | 8 studies | 43% ± 20% | |
fibroblast | 8 studies | 26% ± 9% | |
B cell | 7 studies | 24% ± 7% | |
CD16-negative, CD56-bright natural killer cell, human | 7 studies | 17% ± 1% | |
neuron | 6 studies | 36% ± 15% | |
epithelial cell | 6 studies | 29% ± 9% | |
interneuron | 6 studies | 45% ± 21% | |
macrophage | 6 studies | 35% ± 8% | |
pericyte | 6 studies | 32% ± 14% | |
adipocyte | 6 studies | 28% ± 9% | |
natural killer cell | 5 studies | 22% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 17% ± 1% | |
smooth muscle cell | 5 studies | 22% ± 4% | |
granule cell | 4 studies | 25% ± 6% | |
myeloid cell | 4 studies | 18% ± 1% | |
lymphocyte | 4 studies | 26% ± 9% | |
naive B cell | 4 studies | 18% ± 2% | |
endothelial cell of lymphatic vessel | 4 studies | 35% ± 2% | |
T cell | 3 studies | 21% ± 4% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
GABAergic interneuron | 3 studies | 32% ± 11% | |
glial cell | 3 studies | 26% ± 10% | |
plasma cell | 3 studies | 26% ± 7% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
dendritic cell | 3 studies | 21% ± 5% | |
ciliated cell | 3 studies | 21% ± 2% | |
abnormal cell | 3 studies | 27% ± 8% | |
neural progenitor cell | 3 studies | 32% ± 14% | |
connective tissue cell | 3 studies | 15% ± 0% | |
type I pneumocyte | 3 studies | 26% ± 7% | |
type II pneumocyte | 3 studies | 21% ± 6% | |
goblet cell | 3 studies | 25% ± 11% | |
mast cell | 3 studies | 23% ± 1% | |
plasmacytoid dendritic cell | 3 studies | 20% ± 4% | |
mural cell | 3 studies | 31% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5466.85 | 1443 / 1445 | 100% | 21.01 | 183 / 183 |
lung | 100% | 6595.60 | 578 / 578 | 100% | 16.82 | 1151 / 1155 |
brain | 100% | 5243.34 | 2631 / 2642 | 100% | 27.25 | 703 / 705 |
breast | 100% | 6299.07 | 459 / 459 | 99% | 19.02 | 1109 / 1118 |
thymus | 100% | 9439.08 | 653 / 653 | 99% | 21.49 | 600 / 605 |
intestine | 100% | 6540.81 | 966 / 966 | 99% | 11.86 | 522 / 527 |
bladder | 100% | 6429.71 | 21 / 21 | 99% | 13.86 | 499 / 504 |
prostate | 100% | 7020.57 | 245 / 245 | 99% | 13.78 | 497 / 502 |
ovary | 100% | 8862.39 | 180 / 180 | 99% | 11.89 | 425 / 430 |
pancreas | 100% | 3126.60 | 327 / 328 | 98% | 15.88 | 175 / 178 |
uterus | 100% | 8338.95 | 170 / 170 | 98% | 15.83 | 449 / 459 |
stomach | 100% | 3922.06 | 358 / 359 | 98% | 12.29 | 280 / 286 |
adrenal gland | 100% | 4187.62 | 258 / 258 | 97% | 13.35 | 224 / 230 |
kidney | 100% | 5197.43 | 89 / 89 | 96% | 17.75 | 869 / 901 |
skin | 100% | 4951.54 | 1809 / 1809 | 91% | 14.09 | 430 / 472 |
liver | 99% | 2054.14 | 224 / 226 | 79% | 6.29 | 319 / 406 |
adipose | 100% | 5805.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6371.85 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 6812.92 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.20 | 1 / 1 |
heart | 98% | 3111.60 | 844 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 2102.76 | 782 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 15.18 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.83 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 66% | 7.16 | 53 / 80 |
peripheral blood | 65% | 2245.94 | 601 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | DMTF1 |
Protein name | Cyclin D binding myb like transcription factor 1 Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1) |
Synonyms | DMP1 |
Description | FUNCTION: Transcriptional activator which activates the CDKN2A/ARF locus in response to Ras-Raf signaling, thereby promoting p53/TP53-dependent growth arrest (By similarity). Binds to the consensus sequence 5'-CCCG[GT]ATGT-3' (By similarity). Isoform 1 may cooperate with MYB to activate transcription of the ANPEP gene. Isoform 2 may antagonize transcriptional activation by isoform 1. . |
Accessions | ENST00000428819.5 ENST00000582925.5 C9J4F7 E7EPA0 J3QKU5 ENST00000432366.6 C9JGT5 ENST00000547146.6 ENST00000425406.5 [Q9Y222-4] ENST00000432937.6 [Q9Y222-5] ENST00000579677.5 [Q9Y222-2] J3KRC1 C9JFR2 ENST00000430405.7 Q9Y222 ENST00000425705.2 ENST00000454008.6 ENST00000449088.7 ENST00000413276.6 ENST00000412139.6 [Q9Y222-2] ENST00000579592.5 J3QLW3 C9JLR5 ENST00000582204.1 ENST00000420131.5 ENST00000414630.6 C9J8Y5 ENST00000446796.6 A0A1D5RMP8 ENST00000579850.5 ENST00000448598.5 C9JED5 J3QLN9 ENST00000584619.5 [Q9Y222-2] ENST00000447863.5 [Q9Y222-3] ENST00000453049.5 C9K0K9 H7C388 F8VXY9 C9JVQ7 ENST00000423590.6 C9JZZ6 ENST00000331242.12 [Q9Y222-1] ENST00000434534.5 ENST00000394703.9 [Q9Y222-1] C9K0L9 |